[1]
T. Suttichaimongkol, M. Mitpracha, K. Tangvoraphonkchai, P. Sadeea, K. Sawanyawisuth, and W. Sukeepaisarnjaroen, “PIVKA-II or AFP has better diagnostic properties for hepatocellular carcinoma diagnosis in high-risk patients”, J Circ Biomark, vol. 12, no. 1, pp. 12–16, Feb. 2023.